Back
Savara Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
32
SVRA
Savara
Last Price:
3.82
Seasonality Move:
0.84%
Sell
40
MDGL
Madrigal Pharmaceuticals
Last Price:
208.42
Seasonality Move:
30.52%
Sell
32
Savara (SVRA)
is a Sell
Is Savara a Buy, Sell or Hold?
- The current Savara [SVRA] share price is $3.82. The Score for SVRA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- SVRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $208.41. The Score for MDGL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SVRA Stock Price Chart
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $208.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight buying pressure.
SVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 35.17 | Sell |
| Chaikin Money Flow: | -88643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.06 - 4.5) | Sell |
| Bollinger Bands (100): | (4 - 4.6) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.61 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | 56748 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (215.25 - 242.01) | Sell |
| Bollinger Bands (100): | (227.78 - 277.26) | Sell |
SVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Sell |
| 20-day SMA: | 4.26 | Sell |
| 50-day SMA: | 4.29 | Sell |
| 200-day SMA: | 4.56 | Sell |
| 8-day EMA: | 4.03 | Sell |
| 20-day EMA: | 4.19 | Sell |
| 50-day EMA: | 4.28 | Sell |
| 200-day EMA: | 4.27 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 211.02 | Sell |
| 20-day SMA: | 224.84 | Sell |
| 50-day SMA: | 242.85 | Sell |
| 200-day SMA: | 242.12 | Sell |
| 8-day EMA: | 212.56 | Sell |
| 20-day EMA: | 222.92 | Sell |
| 50-day EMA: | 237.58 | Sell |
| 200-day EMA: | 237.29 | Sell |
Savara Earnings Growth & SVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.02 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Savara Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||